Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)

被引:42
|
作者
Kenny, GE
Cartwright, FD
机构
关键词
D O I
10.1128/AAC.40.4.1048
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibilities of mycoplasmas to a new quinolone, trovafloxacin (CP-99,219), were compared,vith those to sparfloxacin and ofloxacin, Mycoplasma pneumoniae was as susceptible to trovafloxacin (MIC = 0.25 mu g/ml) as to sparfloxacin and fourfold less susceptible to ofloxacin. Mycoplasma hominis was highly susceptible to trovafloxacin (MIC = 0.06 mu g/ml) and sparfloxacin (MIC = 0.03 mu g/ml) and less susceptible to ofloxacin (MIC = 0.5 mu g/ml). Ureaplasma urealyticum was most susceptible to trovafloxacin, with susceptibilities ranging from 0.06 to 0.5 mu g/ml compared with 0.25 to 1.0 mu g of sparfloxacin per ml and 1 to 4 mu g of ofloxacin per ml .
引用
收藏
页码:1048 / 1049
页数:2
相关论文
共 50 条
  • [21] Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in infertile couples
    Daoued, N.
    Hamdoun, M.
    Hannachi, H.
    Braham, M.
    Kacem, K.
    Friji, K.
    Zhioua, F.
    Bahri, O.
    HUMAN REPRODUCTION, 2019, 34 : 200 - 200
  • [22] In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219)
    Barry, AL
    Brown, SD
    Fuchs, PC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) : 324 - 327
  • [23] Microbiology of acute arthropathies among children in Argentina:: Mycoplasma pneumoniae and hominis and Ureaplasma urealyticum
    Poggio, TV
    Orlando, N
    Galanternik, L
    Grinstein, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (04) : 304 - 308
  • [24] Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea
    Hook, EW
    Pinson, GB
    Blalock, CJ
    Johnson, RB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1720 - 1721
  • [25] SUSCEPTIBILITIES OF MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM TO 2 NEW QUINOLONES, SPARFLOXACIN AND WIN-57273
    KENNY, GE
    CARTWRIGHT, FD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1515 - 1516
  • [26] Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men
    Radhouane Gdoura
    Wiem Kchaou
    Chiraz Chaari
    Abir Znazen
    Leila Keskes
    Tarek Rebai
    Adnane Hammami
    BMC Infectious Diseases, 7
  • [27] Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men
    Gdoura, Radhouane
    Kchaou, Wiem
    Chaari, Chiraz
    Znazen, Abir
    Keskes, Leila
    Rebai, Tarek
    Hammami, Adnane
    BMC INFECTIOUS DISEASES, 2007, 7 (1) : 129
  • [28] Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
    Gootz, TD
    Zaniewski, R
    Haskell, S
    Schmieder, B
    Tankovic, J
    Girard, D
    Courvalin, P
    Polzer, RJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2691 - 2697
  • [29] PHARMACOKINETICS AND SAFETY OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE ANTIBIOTIC, FOLLOWING ADMINISTRATION OF SINGLE ORAL DOSES TO HEALTHY MALE-VOLUNTEERS
    TENG, RL
    HARRIS, SC
    NIX, DE
    SCHENTAG, JJ
    FOULDS, G
    LISTON, TE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (02) : 385 - 394
  • [30] ANTIMICROBIAL RESISTANCE OF UREAPLASMA UREALYTICUM AND MYCOPLASMA HOMINIS IN THE ROMANIAN POPULATION
    Cutoiu, Ana
    Boda, Daniel
    FARMACIA, 2023, 71 (01) : 65 - 71